{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T16:27:23Z","timestamp":1791563243547,"version":"4.3.4"},"reference-count":115,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,1,23]],"date-time":"2020-01-23T00:00:00Z","timestamp":1579737600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010663","name":"H2020 European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.00021","type":"journal-article","created":{"date-parts":[[2020,1,22]],"date-time":"2020-01-22T23:30:21Z","timestamp":1579735821000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":68,"title":["Glycosylated Biotherapeutics: Immunological Effects of N-Glycolylneuraminic Acid"],"prefix":"10.3389","volume":"11","author":[{"given":"Sharon","family":"Yehuda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vered","family":"Padler-Karavani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,1,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jbiotec.2017.04.028","article-title":"Therapeutic glycoprotein production in mammalian cells","volume":"251","author":"Lalonde","year":"2017","journal-title":"J Biotechnol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"147","DOI":"10.5661\/bger-28-147","article-title":"Production platforms for biotherapeutic glycoproteins. Occurrence, impact, and challenges of non-human sialylation","volume":"28","author":"Ghaderi","year":"2012","journal-title":"Biotechnol Genet Eng Rev."},{"key":"B3","article-title":"Chapter 6: Glycosyl transferases and glycan-processing enzymes","volume-title":"Essentials of Glycobiology.","author":"Rini","year":"2009"},{"key":"B4","article-title":"Chapter 8: A genomic view of glycobiology","volume-title":"Essentials of Glycobiology.","author":"Henrissat","year":"2015"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e12424","DOI":"10.1111\/xen.12424","article-title":"Evolution of sialic acids: implications in xenotransplant biology","volume":"25","author":"Paul","year":"2018","journal-title":"Xenotransplantation."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.chembiol.2013.12.010","article-title":"The challenge and promise of glycomics","volume":"21","author":"Cummings","year":"2014","journal-title":"Chem Biol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1146\/annurev.immunol.25.022106.141702","article-title":"The impact of glycosylation on the biological function and structure of human immunoglobulins","volume":"25","author":"Arnold","year":"2007","journal-title":"Annu Rev Immunol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.copbio.2009.10.008","article-title":"Expression systems for therapeutic glycoprotein production","volume":"20","author":"Durocher","year":"2009","journal-title":"Curr Opin Biotechnol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s10719-009-9261-x","article-title":"Carbohydrate analysis throughout the development of a protein therapeutic","volume":"27","author":"Higgins","year":"2009","journal-title":"Glycoconj J"},{"key":"B10","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.it.2017.02.004","article-title":"The immunoregulatory roles of antibody glycosylation","volume":"38","author":"Jennewein","year":"2017","journal-title":"Trends Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s13238-017-0408-4","article-title":"Pharmacokinetics of monoclonal antibodies and Fc-fusion proteins","volume":"9","author":"Liu","year":"2018","journal-title":"Protein Cell."},{"key":"B12","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ejpb.2019.03.018","article-title":"N-glycans of complex glycosylated biopharmaceuticals and their impact on protein clearance","volume":"139","author":"Higel","year":"2019","journal-title":"Eur J Pharm Biopharm."},{"key":"B13","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.coche.2018.08.007","article-title":"Computational tools for predicting and controlling the glycosylation of biopharmaceuticals","volume":"22","author":"Kontoravdi","year":"2018","journal-title":"Curr Opin Chem Eng"},{"key":"B14","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.1002\/jps.21684","article-title":"Increasing the sialylation of therapeutic glycoproteins: the potential of the sialic acid biosynthetic pathway","volume":"98","author":"Bork","year":"2009","journal-title":"J Pharm Sci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.3389\/fimmu.2019.01296","article-title":"Conceptual approaches to modulating antibody effector functions and circulation half-life","volume":"10","author":"Saunders","year":"2019","journal-title":"Front Immunol."},{"key":"B16","first-page":"169","article-title":"The asialoglycoprotein receptor: properties and modulation by ligand","volume":"300","author":"Weiss","year":"1989","journal-title":"Prog Clin Biol Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/j.1432-1033.1990.tb15417.x","article-title":"The role of carbohydrate in recombinant human erythropoietin","volume":"188","author":"Tsuda","year":"1990","journal-title":"Eur J Biochem."},{"key":"B18","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/0003-9861(83)90449-6","article-title":"Effect of carbohydrate on protein solubility","volume":"220","author":"Lawson","year":"1983","journal-title":"Arch Biochem Biophys."},{"key":"B19","doi-asserted-by":"publisher","first-page":"520","DOI":"10.3389\/fimmu.2014.00520","article-title":"IgG subclasses and allotypes: from structure to effector functions","volume":"5","author":"Vidarsson","year":"2014","journal-title":"Front Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3390\/antib8020030","article-title":"The ligands for human IgG and their effector functions","volume":"8","author":"de Taeye","year":"2019","journal-title":"Antibodies"},{"key":"B21","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1021\/bp040016j","article-title":"Glycosylation of recombinant antibody therapeutics","volume":"21","author":"Jefferis","year":"2005","journal-title":"Biotechnol Prog."},{"key":"B22","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ab.2007.01.023","article-title":"Structural characterization of N-linked oligosaccharides on monoclonal antibody cetuximab by the combination of orthogonal matrix-assisted laser desorption\/ionization hybrid quadrupole-quadrupole time-of-flight tandem mass spectrometry and sequential enzymatic digestion","volume":"364","author":"Qian","year":"2007","journal-title":"Anal Biochem."},{"key":"B23","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1111\/imr.12342","article-title":"Fc\u03b3R requirements leading to successful immunotherapy","volume":"268","author":"Dahal","year":"2015","journal-title":"Immunol Rev."},{"key":"B24","doi-asserted-by":"publisher","first-page":"3490","DOI":"10.1074\/jbc.H118.001955","article-title":"Antibody receptors steal the sweet spotlight","volume":"293","author":"Oliva","year":"2018","journal-title":"J Biol Chem."},{"key":"B25","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.autrev.2014.02.005","article-title":"Impact of autoantibody glycosylation in autoimmune diseases","volume":"13","author":"Goulabchand","year":"2014","journal-title":"Autoimmun Rev."},{"key":"B26","doi-asserted-by":"publisher","first-page":"25957","DOI":"10.1038\/srep25957","article-title":"Disease-specific IgG Fc N-glycosylation as personalized biomarkers to differentiate gastric cancer from benign gastric diseases","volume":"6","author":"Zhang","year":"2016","journal-title":"Sci Rep."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.3390\/ijms18122632","article-title":"Aberrant N-glycosylation profile of serum immunoglobulins is a diagnostic biomarker of urothelial carcinomas","volume":"18","author":"Tanaka","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B28","doi-asserted-by":"publisher","first-page":"28098","DOI":"10.1038\/srep28098","article-title":"Glycosylation of plasma IgG in colorectal cancer prognosis","volume":"6","author":"Theodoratou","year":"2016","journal-title":"Sci Rep"},{"key":"B29","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.smim.2018.05.003","article-title":"Antibody glycosylation in inflammation, disease and vaccination","volume":"39","author":"Alter","year":"2018","journal-title":"Semin Immunol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/nrd2804","article-title":"Glycosylation as a strategy to improve antibody-based therapeutics","volume":"8","author":"Jefferis","year":"2009","journal-title":"Nat Rev Drug Discov."},{"key":"B31","doi-asserted-by":"publisher","first-page":"3466","DOI":"10.1074\/jbc.M210665200","article-title":"The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity","volume":"278","author":"Shinkawa","year":"2003","journal-title":"J Biol Chem."},{"key":"B32","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.coi.2008.06.007","article-title":"Terminal sugars of Fc glycans influence antibody effector functions of IgGs","volume":"20","author":"Raju","year":"2008","journal-title":"Curr Opin Immunol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nm0395-237","article-title":"Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein","volume":"1","author":"Malhotra","year":"1995","journal-title":"Nat Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1126\/science.1129594","article-title":"Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation","volume":"313","author":"Kaneko","year":"2006","journal-title":"Science."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.3389\/fimmu.2018.02485","article-title":"Improving immunotherapy through glycodesign","volume":"9","author":"Buettner","year":"2018","journal-title":"Front Immunol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"601","DOI":"10.3389\/fimmu.2019.00601","article-title":"Evaluation of in vitro assays to assess the modulation of dendritic cells functions by therapeutic antibodies and aggregates","volume":"10","author":"Morgan","year":"2019","journal-title":"Front Immunol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.3109\/07388551.2015.1084266","article-title":"Human cell lines for biopharmaceutical manufacturing: history, status, and future perspectives","volume":"36","author":"Dumont","year":"2016","journal-title":"Crit Rev Biotechnol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"e1700234","DOI":"10.1002\/biot.201700234","article-title":"Glycoengineering in CHO cells: advances in systems biology","volume":"13","author":"Tejwani","year":"2018","journal-title":"Biotechnol J."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1016\/j.biotechadv.2018.06.008","article-title":"Supplementing glycosylation: a review of applying nucleotide-sugar precursors to growth medium to affect therapeutic recombinant protein glycoform distributions","volume":"36","author":"Blondeel","year":"2018","journal-title":"Biotechnol Adv."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1016\/j.biotechadv.2015.10.015","article-title":"The art of CHO cell engineering: a comprehensive retrospect and future perspectives","volume":"33","author":"Fischer","year":"2015","journal-title":"Biotechnol Adv."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1002\/biot.201400652","article-title":"A global RNA-seq-driven analysis of CHO host and production cell lines reveals distinct differential expression patterns of genes contributing to recombinant antibody glycosylation","volume":"10","author":"K\u00f6nitzer","year":"2015","journal-title":"Biotechnol J."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.coisb.2017.05.019","article-title":"Improvements in protein production in mammalian cells from targeted metabolic engineering","volume":"6","author":"Richelle","year":"2017","journal-title":"Curr Opin Syst Biol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.sbi.2016.08.008","article-title":"Modulating carbohydrate-protein interactions through glycoengineering of monoclonal antibodies to impact cancer physiology","volume":"40","author":"Chiang","year":"2016","journal-title":"Curr Opin Struct Biol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.copbio.2014.08.004","article-title":"Systems glycobiology for glycoengineering","volume":"30","author":"Spahn","year":"2014","journal-title":"Curr Opin Biotechnol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1399-3089.2011.00622.x","article-title":"Potential impact of the non-human sialic acid N-glycolylneuraminic acid on transplant rejection risk","volume":"18","author":"Padler-Karavani","year":"2011","journal-title":"Xenotransplantation."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1093\/glycob\/cww088","article-title":"Natural anti-carbohydrate antibodies contributing to evolutionary survival of primates in viral epidemics","volume":"26","author":"Galili","year":"2016","journal-title":"Glycobiology."},{"key":"B47","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1093\/glycob\/cwn072","article-title":"Diversity in specificity, abundance, and composition of anti-Neu5Gc antibodies in normal humans: potential implications for disease","volume":"18","author":"Padler-Karavani","year":"2008","journal-title":"Glycobiology."},{"key":"B48","doi-asserted-by":"publisher","first-page":"789","DOI":"10.3389\/fimmu.2019.00789","article-title":"Absence of Neu5Gc and presence of Anti-Neu5Gc antibodies in humans-an evolutionary perspective","volume":"10","author":"Altman","year":"2019","journal-title":"Front Immunol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"56094","DOI":"10.3791\/56094","article-title":"Profiling Anti-Neu5Gc IgG in human sera with a sialoglycan microarray assay","volume":"125","author":"Leviatan","year":"2017","journal-title":"J Vis Exp"},{"key":"B50","doi-asserted-by":"publisher","first-page":"12045","DOI":"10.1073\/pnas.2131556100","article-title":"Human uptake and incorporation of an immunogenic nonhuman dietary sialic acid","volume":"100","author":"Tangvoranuntakul","year":"2003","journal-title":"Proc Natl Acad Sci USA."},{"key":"B51","doi-asserted-by":"publisher","first-page":"228","DOI":"10.4049\/jimmunol.175.1.228","article-title":"Effects of natural human antibodies against a nonhuman sialic acid that metabolically incorporates into activated and malignant immune cells","volume":"175","author":"Nguyen","year":"2005","journal-title":"J Immunol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3389\/fonc.2014.00033","article-title":"Involvement of a non-human sialic acid in human cancer","volume":"4","author":"Samraj","year":"2014","journal-title":"Front Oncol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"807","DOI":"10.3389\/fimmu.2019.00807","article-title":"From \u201cserum sickness\u201d to \u201cxenosialitis\u201d: past, present, and future significance of the non-human sialic acid Neu5Gc","volume":"10","author":"Dhar","year":"2019","journal-title":"Front Immunol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jaut.2017.07.011","article-title":"Are humans prone to autoimmunity? Implications from evolutionary changes in hominin sialic acid biology","volume":"83","author":"Varki","year":"2017","journal-title":"J Autoimmun."},{"key":"B55","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.mam.2016.07.002","article-title":"Human risk of diseases associated with red meat intake: analysis of current theories and proposed role for metabolic incorporation of a non-human sialic acid","volume":"51","author":"Alisson-Silva","year":"2016","journal-title":"Mol Aspects Med."},{"key":"B56","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1073\/pnas.1417508112","article-title":"A red meat-derived glycan promotes inflammation and cancer progression","volume":"112","author":"Samraj","year":"2015","journal-title":"Proc Natl Acad Sci USA."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1002\/cbic.201700077","article-title":"Biochemical, cellular, physiological, and pathological consequences of human loss of N-glycolylneuraminic acid","volume":"18","author":"Okerblom","year":"2017","journal-title":"Chembiochem."},{"key":"B58","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.3389\/fimmu.2019.02004","article-title":"Synthesis of N-glycolylneuraminic acid (Neu5Gc) and its glycosides","volume":"10","author":"Kooner","year":"2019","journal-title":"Front Immunol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3389\/fmolb.2019.00088","article-title":"Natural and synthetic sialylated glycan microarrays and their applications","volume":"6","author":"McQuillan","year":"2019","journal-title":"Front Mol Biosci."},{"key":"B60","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3389\/fmolb.2019.00057","article-title":"The structural complexity and animal tissue distribution of N-glycolylneuraminic acid (Neu5Gc)-terminated glycans. Implications for their immunogenicity in clinical xenografting","volume":"6","author":"Breimer","year":"2019","journal-title":"Front Mol Biosci."},{"key":"B61","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1038\/nbt.1651","article-title":"Implications of the presence of N-glycolylneuraminic acid in recombinant therapeutic glycoproteins","volume":"28","author":"Ghaderi","year":"2010","journal-title":"Nat Biotechnol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"4655","DOI":"10.1172\/JCI82267","article-title":"Rabbit antithymocyte globulin-induced serum sickness disease and human kidney graft survival","volume":"125","author":"Couvrat-Desvergnes","year":"2015","journal-title":"J Clin Invest."},{"key":"B63","doi-asserted-by":"publisher","first-page":"112236","DOI":"10.18632\/oncotarget.23096","article-title":"Glycan microarray reveal induced IgGs repertoire shift against a dietary carbohydrate in response to rabbit anti-human thymocyte therapy","volume":"8","author":"Amon","year":"2017","journal-title":"Oncotarget."},{"key":"B64","doi-asserted-by":"publisher","first-page":"e357","DOI":"10.1097\/TXD.0000000000000772","article-title":"Poor patient and graft outcome after induction treatment by antithymocyte globulin in recipients of a kidney graft after nonrenal organ transplantation","volume":"4","author":"Mai","year":"2018","journal-title":"Transplant Direct."},{"key":"B65","doi-asserted-by":"publisher","first-page":"e12535","DOI":"10.1111\/xen.12535","article-title":"Elicited and pre-existing anti-Neu5Gc antibodies differentially affect human endothelial cells transcriptome","volume":"26","author":"Le Berre","year":"2019","journal-title":"Xenotransplantation"},{"key":"B66","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1021\/cr000407m","article-title":"Chemical diversity in the sialic acids and related alpha-keto acids: an evolutionary perspective","volume":"102","author":"Angata","year":"2002","journal-title":"Chem Rev."},{"key":"B67","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/ajpa.10018","article-title":"Loss of N-glycolylneuraminic acid in humans: mechanisms, consequences, and implications for hominid evolution","volume":"33","author":"Varki","year":"2001","journal-title":"Am J Phys Anthropol Suppl."},{"key":"B68","doi-asserted-by":"publisher","first-page":"11751","DOI":"10.1073\/pnas.95.20.11751","article-title":"A mutation in human CMP-sialic acid hydroxylase occurred after the Homo-Pan divergence","volume":"95","author":"Chou","year":"1998","journal-title":"Proc Natl Acad Sci USA."},{"key":"B69","doi-asserted-by":"publisher","first-page":"11399","DOI":"10.1073\/pnas.191268198","article-title":"Alu-mediated inactivation of the human CMP- N-acetylneuraminic acid hydroxylase gene","volume":"98","author":"Hayakawa","year":"2001","journal-title":"Proc Natl Acad Sci USA."},{"key":"B70","doi-asserted-by":"publisher","first-page":"11736","DOI":"10.1073\/pnas.182257399","article-title":"Inactivation of CMP-N-acetylneuraminic acid hydroxylase occurred prior to brain expansion during human evolution","volume":"99","author":"Chou","year":"2002","journal-title":"Proc Natl Acad Sci USA."},{"key":"B71","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/S0300-9084(01)01303-7","article-title":"N-Glycolylneuraminic acid in human tumours","volume":"83","author":"Malykh","year":"2001","journal-title":"Biochimie."},{"key":"B72","doi-asserted-by":"publisher","first-page":"4228","DOI":"10.1074\/jbc.M412040200","article-title":"Mechanism of uptake and incorporation of the non-human sialic acid N-glycolylneuraminic acid into human cells","volume":"280","author":"Bardor","year":"2005","journal-title":"J Biol Chem."},{"key":"B73","doi-asserted-by":"publisher","first-page":"28852","DOI":"10.1074\/jbc.M112.364182","article-title":"Metabolism of vertebrate amino sugars with N-glycolyl groups: mechanisms underlying gastrointestinal incorporation of the non-human sialic acid xeno-autoantigen n-glycolylneuraminic acid","volume":"287","author":"Banda","year":"2012","journal-title":"J Biol Chem."},{"key":"B74","doi-asserted-by":"publisher","first-page":"28865","DOI":"10.1074\/jbc.M112.363549","article-title":"Metabolism of vertebrate amino sugars with N-glycolyl groups: elucidating the intracellular fate of the non-human sialic acid n-glycolylneuraminic acid","volume":"287","author":"Bergfeld","year":"2012","journal-title":"J Biol Chem."},{"key":"B75","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.carres.2014.02.004","article-title":"Glycans in immune recognition and response","volume":"389","author":"Amon","year":"2014","journal-title":"Carbohydr Res."},{"key":"B76","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1034\/j.1399-3089.2002.02138.x","article-title":"Anti-N-glycolylneuraminic acid antibodies identified in healthy human serum","volume":"9","author":"Zhu","year":"2002","journal-title":"Xenotransplantation."},{"key":"B77","doi-asserted-by":"publisher","first-page":"3352","DOI":"10.1158\/0008-5472.CAN-10-4102","article-title":"Human xeno-autoantibodies against a non-human sialic acid serve as novel serum biomarkers and immunotherapeutics in cancer","volume":"71","author":"Padler-Karavani","year":"2011","journal-title":"Cancer Res."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1021\/acs.bioconjchem.9b00273","article-title":"Differential recognition of diet-derived Neu5Gc-neoantigens on glycan microarrays by carbohydrate-specific pooled human IgG and IgA antibodies","volume":"30","author":"Leviatan","year":"2019","journal-title":"Bioconjug Chem"},{"key":"B79","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1021\/ac2030893","article-title":"LC-MS analysis of polyclonal human anti-Neu5Gc xeno-autoantibodies immunoglobulin G Subclass and partial sequence using multistep intravenous immunoglobulin affinity purification and multienzymatic digestion","volume":"84","author":"Lu","year":"2012","journal-title":"Anal Chem."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1084\/jem.20100575","article-title":"Novel mechanism for the generation of human xeno-autoantibodies against the nonhuman sialic acid N-glycolylneuraminic acid","volume":"207","author":"Taylor","year":"2010","journal-title":"J Exp Med."},{"key":"B81","doi-asserted-by":"publisher","first-page":"987","DOI":"10.2337\/db16-1060","article-title":"Neu5Gc and \u03b11-3 GAL xenoantigen knockout does not affect glycemia homeostasis and insulin secretion in pigs","volume":"66","author":"Salama","year":"2017","journal-title":"Diabetes."},{"key":"B82","doi-asserted-by":"publisher","first-page":"e58443","DOI":"10.1371\/journal.pone.0058443","article-title":"A simple method for assessment of human anti-Neu5Gc antibodies applied to Kawasaki disease","volume":"8","author":"Padler-Karavani","year":"2013","journal-title":"PLoS ONE."},{"key":"B83","doi-asserted-by":"publisher","first-page":"2907","DOI":"10.4049\/jimmunol.1301195","article-title":"Long-term IgG response to porcine Neu5Gc antigens without transmission of PERV in burn patients treated with porcine skin xenografts","volume":"191","author":"Scobie","year":"2013","journal-title":"J Immunol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"e0197464","DOI":"10.1371\/journal.pone.0197464","article-title":"Polyclonal human antibodies against glycans bearing red meat-derived non-human sialic acid N-glycolylneuraminic acid are stable, reproducible, complex and vary between individuals: Total antibody levels are associated with colorectal cancer risk","volume":"13","author":"Samraj","year":"2018","journal-title":"PLoS ONE."},{"key":"B85","doi-asserted-by":"publisher","first-page":"18936","DOI":"10.1073\/pnas.0803943105","article-title":"Evidence for a human-specific mechanism for diet and antibody-mediated inflammation in carcinoma progression","volume":"105","author":"Hedlund","year":"2008","journal-title":"Proc Natl Acad Sci USA."},{"key":"B86","doi-asserted-by":"publisher","first-page":"5225","DOI":"10.1182\/blood-2009-05-220400","article-title":"Evidence for a novel human-specific xeno-auto-antibody response against vascular endothelium","volume":"114","author":"Pham","year":"2009","journal-title":"Blood."},{"key":"B87","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1093\/ije\/dyz146","article-title":"Meat intake and risk of hepatocellular carcinoma in two large US prospective cohorts of women and men","volume":"48","author":"Ma","year":"2019","journal-title":"Int J Epidemiol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1080\/10408398.2014.972498","article-title":"Consumption of red\/processed meat and colorectal carcinoma: possible mechanisms underlying the significant association","volume":"56","author":"Hammerling","year":"2016","journal-title":"Crit Rev Food Sci Nutr."},{"key":"B89","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1001\/archinte.166.20.2253","article-title":"Red meat intake and risk of breast cancer among premenopausal women","volume":"166","author":"Cho","year":"2006","journal-title":"Arch Intern Med."},{"key":"B90","doi-asserted-by":"publisher","first-page":"16036","DOI":"10.1073\/pnas.1902902116","article-title":"Human species-specific loss of CMP-N-acetylneuraminic acid hydroxylase enhances atherosclerosis via intrinsic and extrinsic mechanisms","volume":"116","author":"Kawanishi","year":"2019","journal-title":"Proc Natl Acad Sci USA."},{"key":"B91","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1161\/CIRCULATIONAHA.109.924977","article-title":"Red and processed meat consumption and risk of incident coronary heart disease, stroke, and diabetes mellitus: a systematic review and meta-analysis","volume":"121","author":"Micha","year":"2010","journal-title":"Circulation."},{"key":"B92","doi-asserted-by":"publisher","first-page":"l4897","DOI":"10.1136\/bmj.l4897","article-title":"Risks of ischaemic heart disease and stroke in meat eaters, fish eaters, and vegetarians over 18 years of follow-up: results from the prospective EPIC-Oxford study","volume":"366","author":"Tong","year":"2019","journal-title":"BMJ."},{"key":"B93","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.mehy.2013.01.036","article-title":"Missing links in multiple sclerosis etiology. A working connecting hypothesis","volume":"80","author":"Soulillou","year":"2013","journal-title":"Med Hypotheses."},{"key":"B94","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1146\/annurev-pathol-011110-130315","article-title":"Biomedical differences between human and nonhuman hominids: potential roles for uniquely human aspects of sialic acid biology","volume":"6","author":"Varki","year":"2011","journal-title":"Annu Rev Pathol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1046\/j.1365-2141.2003.04307.x","article-title":"Relationships between the N-glycan structures and biological activities of recombinant human erythropoietins produced using different culture conditions and purification procedures","volume":"121","author":"Yuen","year":"2003","journal-title":"Br J Haematol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1093\/oxfordjournals.jbchem.a124721","article-title":"Immunogenicity of N-glycolylneuraminic acid-containing carbohydrate chains of recombinant human erythropoietin expressed in Chinese hamster ovary cells","volume":"117","author":"Noguchi","year":"1995","journal-title":"J Biochem."},{"key":"B97","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0022-1759(01)00559-2","article-title":"Myeloma expression systems","volume":"261","author":"Yoo","year":"2002","journal-title":"J Immunol Methods."},{"key":"B98","doi-asserted-by":"crossref","first-page":"20216","DOI":"10.1016\/S0021-9258(19)47049-X","article-title":"Biosynthesis of N-glycolyneuraminic acid. The primary site of hydroxylation of N-acetylneuraminic acid is the cytosolic sugar nucleotide pool","volume":"264","author":"Muchmore","year":"1989","journal-title":"J Biol Chem."},{"key":"B99","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/xen.12260","article-title":"Characterization of immunogenic Neu5Gc in bioprosthetic heart valves","volume":"23","author":"Reuven","year":"2016","journal-title":"Xenotransplantation."},{"key":"B100","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1097\/MOT.0000000000000582","article-title":"Progress and challenges in lung xenotransplantation: an update","volume":"23","author":"Burdorf","year":"2018","journal-title":"Curr Opin Organ Transplant."},{"key":"B101","doi-asserted-by":"publisher","first-page":"12345","DOI":"10.1111\/xen.12345","article-title":"The role of sialic acids in the immune recognition of xenografts","volume":"24","author":"French","year":"2017","journal-title":"Xenotransplantation"},{"key":"B102","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.ijsu.2015.07.724","article-title":"Recent investigations into pig antigen and anti-pig antibody expression","volume":"23","author":"Byrne","year":"2015","journal-title":"Int J Surg."},{"key":"B103","doi-asserted-by":"publisher","first-page":"e12524","DOI":"10.1111\/xen.12524","article-title":"Generation of cattle knockout for galactose-\u03b11,3-galactose and N-glycolylneuraminic acid antigens","volume":"26","author":"Perota","year":"2019","journal-title":"Xenotransplantation."},{"key":"B104","doi-asserted-by":"publisher","first-page":"29081","DOI":"10.1038\/srep29081","article-title":"Efficient production of multi-modified pigs for xenotransplantation by \u2018combineering', gene stacking and gene editing","volume":"6","author":"Fischer","year":"2016","journal-title":"Sci Rep."},{"key":"B105","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.actbio.2018.03.055","article-title":"Reducing immunoreactivity of porcine bioprosthetic heart valves by genetically-deleting three major glycan antigens, GGTA1\/\u03b24GalNT2\/CMAH","volume":"72","author":"Zhang","year":"2018","journal-title":"Acta Biomater."},{"key":"B106","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s11892-018-1074-5","article-title":"Will genetic engineering carry xenotransplantation of pig islets to the clinic","volume":"18","author":"Kemter","year":"2018","journal-title":"Curr Diab Rep."},{"key":"B107","doi-asserted-by":"publisher","first-page":"12339","DOI":"10.1111\/xen.12339","article-title":"N-glycolylneuraminic acid knockout reduces erythrocyte sequestration and thromboxane elaboration in an ex vivo pig-to-human xenoperfusion model","volume":"24","author":"Cimeno","year":"2017","journal-title":"Xenotransplantation"},{"key":"B108","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1097\/TP.0000000000001686","article-title":"Anti-Gal and anti-Neu5Gc responses in nonimmunosuppressed patients following treatment with rabbit anti-thymocyte polyclonal IgGs","volume":"101","author":"Salama","year":"2017","journal-title":"Transplantation."},{"key":"B109","doi-asserted-by":"publisher","first-page":"20029","DOI":"10.1038\/srep20029","article-title":"At least two Fc Neu5Gc residues of monoclonal antibodies are required for binding to anti-Neu5Gc antibody","volume":"7","author":"Yu","year":"2016","journal-title":"Sci Rep."},{"key":"B110","doi-asserted-by":"publisher","first-page":"e13069","DOI":"10.1111\/eci.13069","article-title":"Quantitative and qualitative changes in anti-Neu5Gc antibody response following rabbit anti-thymocyte IgG induction in kidney allograft recipients","volume":"49","author":"Rousse","year":"2019","journal-title":"Eur J Clin Invest."},{"key":"B111","doi-asserted-by":"publisher","first-page":"E324","DOI":"10.3390\/cancers10090324","article-title":"No increase in colon cancer risk following induction with Neu5Gc-bearing rabbit anti-T cell IgG (ATG) in recipients of kidney transplants","volume":"10","author":"Soulillou","year":"2018","journal-title":"Cancers"},{"key":"B112","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1159\/000188946","article-title":"Failure of human immunoresponse to N-glycolylneuraminic acid epitope contained in recombinant human erythropoietin","volume":"72","author":"Noguchi","year":"1996","journal-title":"Nephron."},{"key":"B113","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1038\/sj.leu.2404683","article-title":"Mechanisms of action of antithymocyte globulin: T-cell depletion and beyond","volume":"21","author":"Mohty","year":"2007","journal-title":"Leukemia."},{"key":"B114","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/S2213-8587(13)70065-2","article-title":"Antithymocyte globulin treatment for patients with recent-onset type 1 diabetes: 12-month results of a randomised, placebo-controlled, phase 2 trial","volume":"1","author":"Gitelman","year":"2013","journal-title":"Lancet Diabetes Endocrinol."},{"key":"B115","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1021\/acs.bioconjchem.8b00817","article-title":"Presentation mode of glycans affect recognition of human serum anti-Neu5Gc IgG antibodies","volume":"30","author":"Bashir","year":"2019","journal-title":"Bioconjug Chem."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00021\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,23]],"date-time":"2021-02-23T06:37:20Z","timestamp":1614062240000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00021\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,23]]},"references-count":115,"alternative-id":["10.3389\/fimmu.2020.00021"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.00021","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,23]]},"article-number":"21"}}